Alert for PepGen Inc. Investors
Levi & Korsinsky, a prominent law firm, has announced serious news for investors in PepGen Inc. (NASDAQ: PEPG). A class action securities lawsuit has been initiated, targeting purported instances of securities fraud that occurred between March 7, 2024, and March 3, 2025. The firm is currently seeking to represent those shareholders who may have been adversely affected during this period.
Background of the Lawsuit
The core of the case revolves around allegations that PepGen Inc. made misleading statements concerning the efficacy and safety of its leading product candidate, PGN-EDO51. According to the claimants, the company’s communications painted an unrealistically positive picture of the product's potential, suggesting it was more effective than what the evidence would support.
Moreover, the lawsuit asserts that the company’s phase two CONNECT2 study was fraught with dangers and deficiencies that would ultimately hinder its possibility of receiving FDA approval. This led to heightened concerns that PepGen might have to halt the CONNECT2 study, therefore potentially compromising the clinical and regulatory outlook of PGN-EDO51.
The controversy escalated as the accusations indicated that PepGen’s public statements were materially false and misleading. Investors, acting under the assumption that they were investing in a company with solid scientific backing, faced financial losses as the reality began to contradict PepGen's assertions.
What Investors Should Know
Shareholders who suffered losses during the specified time frame are directed to act promptly, as they have until
August 8, 2025, to apply to serve as lead plaintiff in this action. This process, however, is not a prerequisite for participating in any potential recovery from the lawsuit; class members can seek compensation without taking on the responsibilities tied to lead plaintiff status.
It's important to note that there are no upfront costs or financial obligations for those involved. If validated as class members, investors may access compensation based purely on their association with the claims without having to incur any out-of-pocket expenses.
Why Choose Levi & Korsinsky?
For over two decades, Levi & Korsinsky has established a strong reputation for securing significant recoveries for their clients in high-stakes cases. They are considered one of the top securities litigation firms in the United States, according to ISS Securities Class Action Services. With a dedicated team of over seventy professionals, they bring extensive experience and expertise to the table, empowering investors who seek justice in complex financial disputes.
Contact Information
Investors who wish to learn more about this class action lawsuit and check their eligibility can reach out directly to Levi & Korsinsky:
- - Email: [email protected]
- - Telephone: (212) 363-7500
- - Address: 33 Whitehall Street, 17th Floor, New York, NY 10004
For further information, investors can also fill out the submission form on the firm's website. It is crucial for investors to remain vigilant and informed, particularly during such challenging times in the financial markets. Levi & Korsinsky, through its dedicated approach, aims to represent the interests of shareholders and bring accountability where it is due.